Table 3.
Results of Association Testing of HGF SNPs in Multiple Cohorts
| Cohort | rs3735520 |
rs17501108/rs1014091* |
||||||
|---|---|---|---|---|---|---|---|---|
| MAF |
P | OR (95% CI) | MAF |
P | OR (95% CI) | |||
| Controls | Cases | Controls | Cases | |||||
| Pooled+Rep1 | 0.41 | 0.51 | 0.002 | 1.50 (1.15–1.94) | 0.14 | 0.07 | 0.0002 | 2.33 (1.17–3.69) |
| Rep2 | 0.43 | 0.45 | 0.664 | 1.08 (0.76–1.51) | 0.17 | 0.10 | 0.006 | 1.93 (1.20–3.10) |
| US1 | 0.45 | 0.57 | 6.1 × 10−7 | 1.63 (1.35–1.98) | 0.11 | 0.07 | 0.018 | 1.56 (1.07–2.24) |
| US2 | 0.46 | 0.47 | 0.655 | 1.05 (0.86–1.28) | 0.11 | 0.10 | 0.658 | 1.08 (0.77–1.50) |
The minor allele frequency in cases and controls are shown. OR (95% CI) is also shown, expressed with respect to the risk allele defined in the pooled samples.
As rs17501108 and rs1014091 are in very strong LD (r2 = 0.95 in Australian samples), the results for rs17501108 are presented for Australian samples and rs1014091 for U.S. samples, due to different genotyping strategies in the two cohorts.